Sam68 Promotes the Progression of Human Breast Cancer through Inducing Activation of EphA3.
Src-associated in mitosis of 68 kDa (Sam68), is often elevated expressing in human cancers. Overexpression of Sam68 has been shown to be correlated with poor survival prognosis in some cancer patients. However, seldom is known whether Sam68 plays a role in promoting metastasis in breast cancer. The expression of Sam68 protein in breast cancer tissue was detected by immunohistochemistry. Trans-well assay, wound-healing, real-time PCR and Western blotting analysis were used to detect the effect of Sam68 on promoting EMT or metastasis of breast cancer. Next-generation RNA sequencing was used to analyze genes that may be regulated by Sam68. Sam68 plays a positive role in promoting breast cancer metastasis. Sam68 was found to be over expressed in breast cancer along with lymph node metastasis. MMP-9 was also found to be overexpressed in breast cancer tissue and was correlated to the expression of Sam68 (P<0.01). Xenograft in NOD/SCID mice and in vitro experiments confirmed that the invasion and metastatic ability of breast cancer cells was regulated by Sam68. And EPHA3 could be up-regulated by Sam68 in breast cancer. High expression of Sam68 participates in breast cancer metastasis through up-regulating EPHA3 gene.